Global Basal Cell Nevus Syndrome Drug Market Status and Outlook 2018-2025

August 2018 | 145 pages | ID: G7F79DF3AECEN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Adgero Biopharmaceuticals Holdings Inc
• Galderma SA
• Mayne Pharma Group Ltd
• PellePharm Inc
• Transgene SA

Market by Type

• Itraconazole
• Patidegib Hydrochloride
• REM-001
• TG-1042
• Trifarotene
• Others

Market by Application

• Clinic
• Hospital
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Basal Cell Nevus Syndrome Drug Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Itraconazole
  3.1.2 Patidegib Hydrochloride
  3.1.3 REM-001
  3.1.4 TG-1042
  3.1.5 Trifarotene
  3.1.6 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Clinic
  4.1.2 Hospital
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Itraconazole Production by Region
    6.1.1.2 Patidegib Hydrochloride Production by Region
    6.1.1.3 REM-001 Production by Region
    6.1.1.4 TG-1042 Production by Region
    6.1.1.5 Trifarotene Production by Region
    6.1.1.6 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Clinic Production by Region
    6.1.2.2 Hospital Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Itraconazole Demand by Region
    6.2.1.2 Patidegib Hydrochloride Demand by Region
    6.2.1.3 REM-001 Demand by Region
    6.2.1.4 TG-1042 Demand by Region
    6.2.1.5 Trifarotene Demand by Region
    6.2.1.6 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Clinic Demand by Region
    6.2.2.2 Hospital Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Adgero Biopharmaceuticals Holdings Inc
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Galderma SA
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Mayne Pharma Group Ltd
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 PellePharm Inc
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Transgene SA
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Basal Cell Nevus Syndrome Drug Industry Dynamics & Regulations List
Table Global Basal Cell Nevus Syndrome Drug Sales Revenue, Cost and Margin, 2015-2018E
Table Global Basal Cell Nevus Syndrome Drug Market Status by Type 2015-2018E, in USD Million
Table Global Basal Cell Nevus Syndrome Drug Market Status by Application 2015-2018E, in USD Million
Table Global Basal Cell Nevus Syndrome Drug Market Status by Application 2015-2018E, in Volume
Table Global Basal Cell Nevus Syndrome Drug Market by Region 2015-2018E, in USD Million
Table Global Basal Cell Nevus Syndrome Drug Market Share by Region in 2018, in USD Million
Table Global Basal Cell Nevus Syndrome Drug Market by Region 2015-2018E, in Volume
Table Global Basal Cell Nevus Syndrome Drug Market Share by Region in 2018, in Volume
Table Itraconazole Production Value by Region 2015-2018E, in USD Million
Table Itraconazole Production Volume by Region 2015-2018E, in Volume
Table Patidegib Hydrochloride Production Value by Region 2015-2018E, in USD Million
Table Patidegib Hydrochloride Production Volume by Region 2015-2018E, in Volume
Table REM-001 Production Value by Region 2015-2018E, in USD Million
Table REM-001 Production Volume by Region 2015-2018E, in Volume
Table TG-1042 Production Value by Region 2015-2018E, in USD Million
Table TG-1042 Production Volume by Region 2015-2018E, in Volume
Table Trifarotene Production Value by Region 2015-2018E, in USD Million
Table Trifarotene Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Clinic Production Value by Region 2015-2018E, in USD Million
Table Clinic Production Volume by Region 2015-2018E, in Volume
Table Hospital Production Value by Region 2015-2018E, in USD Million
Table Hospital Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Itraconazole Market Size by Region 2015-2018E, in USD Million
Table Itraconazole Market Size by Region 2015-2018E, in Volume
Table Patidegib Hydrochloride Market Size by Region 2015-2018E, in USD Million
Table Patidegib Hydrochloride Market Size by Region 2015-2018E, in Volume
Table REM-001 Market Size by Region 2015-2018E, in USD Million
Table REM-001 Market Size by Region 2015-2018E, in Volume
Table TG-1042 Market Size by Region 2015-2018E, in USD Million
Table TG-1042 Market Size by Region 2015-2018E, in Volume
Table Trifarotene Market Size by Region 2015-2018E, in USD Million
Table Trifarotene Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Clinic Market Size by Region 2015-2018E, in USD Million
Table Clinic Market Size by Region 2015-2018E, in Volume
Table Hospital Market Size by Region 2015-2018E, in USD Million
Table Hospital Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalBasal Cell Nevus Syndrome Drug Forecast by Type 2019F-2025F, in USD Million
Table Basal Cell Nevus Syndrome Drug Forecast by Type 2019F-2025F, in Volume
Table Basal Cell Nevus Syndrome Drug Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Basal Cell Nevus Syndrome Drug Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Basal Cell Nevus Syndrome Drug Market Forecast by Region 2019F-2025F, in USD Million
Table Basal Cell Nevus Syndrome Drug Market Forecast by Region 2019F-2025F, in Volume
Table Adgero Biopharmaceuticals Holdings Inc Information
Table Basal Cell Nevus Syndrome Drug Sales, Cost, Margin of Adgero Biopharmaceuticals Holdings Inc
Table Galderma SA Information
Table Basal Cell Nevus Syndrome Drug Sales, Cost, Margin of Galderma SA
Table Mayne Pharma Group Ltd Information
Table Basal Cell Nevus Syndrome Drug Sales, Cost, Margin of Mayne Pharma Group Ltd
Table PellePharm Inc Information
Table Basal Cell Nevus Syndrome Drug Sales, Cost, Margin of PellePharm Inc
Table Transgene SA Information
Table Basal Cell Nevus Syndrome Drug Sales, Cost, Margin of Transgene SA
Table Global Basal Cell Nevus Syndrome Drug Sales Revenue by Company 2015-2017, in USD Million
Table Global Basal Cell Nevus Syndrome Drug Sales Volume by Company 2015-2017, in Volume
Table Global Basal Cell Nevus Syndrome Drug Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Basal Cell Nevus Syndrome Drug Picture
Figure Basal Cell Nevus Syndrome Drug Industry Chain Diagram
Figure Global Basal Cell Nevus Syndrome Drug Sales Revenue 2015-2018E, in USD Million
Figure Global Basal Cell Nevus Syndrome Drug Sales Volume 2015-2018E, in Volume
Figure Global Basal Cell Nevus Syndrome Drug Market Status by Type 2015-2018E, in Volume
Figure North America Basal Cell Nevus Syndrome Drug Market Size and Growth 2015-2018E, in USD Million
Figure North America Basal Cell Nevus Syndrome Drug Market Size and Growth 2015-2018E, in Volume
Figure Europe Basal Cell Nevus Syndrome Drug Market Size and Growth 2015-2018E, in USD Million
Figure Europe Basal Cell Nevus Syndrome Drug Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Basal Cell Nevus Syndrome Drug Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Basal Cell Nevus Syndrome Drug Market Size and Growth 2015-2018E, in Volume
Figure South America Basal Cell Nevus Syndrome Drug Market Size and Growth 2015-2018E, in USD Million
Figure South America Basal Cell Nevus Syndrome Drug Market Size and Growth 2015-2018E, in Volume
Figure Middle East Basal Cell Nevus Syndrome Drug Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Basal Cell Nevus Syndrome Drug Market Size and Growth 2015-2018E, in Volume
Figure Africa Basal Cell Nevus Syndrome Drug Market Size and Growth 2015-2018E, in USD Million
Figure Africa Basal Cell Nevus Syndrome Drug Market Size and Growth 2015-2018E, in Volume
Figure Global Basal Cell Nevus Syndrome Drug Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Basal Cell Nevus Syndrome Drug Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Basal Cell Nevus Syndrome Drug Sales Price Forecast 2019F-2025F
Figure Global Basal Cell Nevus Syndrome Drug Gross Margin Forecast 2019F-2025F
Figure Global Basal Cell Nevus Syndrome Drug Sales Revenue by Company in 2018, in USD Million
Figure Global Basal Cell Nevus Syndrome Drug Price by Company in 2018
Figure Global Basal Cell Nevus Syndrome Drug Gross Margin by Company in 2018